메뉴 건너뛰기
BJU International
Volumn 91, Issue 7, 2003, Pages 600-602
Outcome and survival with nonsurgical management of renal cell carcinoma
Author keywords

Conservative management; Renal cell carcinoma; Survival
Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; KIDNEY CARCINOMA; LONG TERM CARE; MALE; METASTASIS; NEPHRECTOMY; PALLIATIVE THERAPY; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TREATMENT PLANNING;
EID: 0038244791     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2003.04173.x     Document Type: Article
Times cited : (11)
References (8)
  • 2
    • 0033074437 scopus 로고    scopus 로고
    • Renal cell carcinoma. Management of advanced disease
    • Figlin RA. Renal cell carcinoma. Management of advanced disease. J Urol 1999; 161: 381-7
    • (1999) J Urol , vol.161 , pp. 381-387
    • Figlin, R.A.1
  • 3
    • 0028929682 scopus 로고
    • Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy
    • Fyfe G, Fisher RI, Rosenberg SA et al. Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy. J Clin Onc 1995; 13: 688-96
    • (1995) J Clin Onc , vol.13 , pp. 688-696
    • Fyfe, G.1    Fisher, R.I.2    Rosenberg, S.A.3
  • 4
    • 0033514050 scopus 로고    scopus 로고
    • Interferon-α and survival in metastatic renal carcinoma: Early results of a randomised controlled trial
    • Medical Research Council Renal Cancer Collaborators. Interferon-α and survival in metastatic renal carcinoma: early results of a randomised controlled trial. Lancet 1999; 353: 14-7
    • (1999) Lancet , vol.353 , pp. 14-17
  • 5
    • 0030751476 scopus 로고    scopus 로고
    • Cytoreductive surgery before high dose interleukin-2 based therapy in patients with metastatic renal cell carcinoma
    • Walther MM, Yang JC, Pass HI et al. Cytoreductive surgery before high dose interleukin-2 based therapy in patients with metastatic renal cell carcinoma. J Urol 1997; 158: 1675-8
    • (1997) J Urol , vol.158 , pp. 1675-1678
    • Walther, M.M.1    Yang, J.C.2    Pass, H.I.3
  • 6
    • 0035818877 scopus 로고    scopus 로고
    • Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer
    • Flanigan RC, Salmon S, Blumenstein BA et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. NEJM 2001; 345: 1655-9
    • (2001) NEJM , vol.345 , pp. 1655-1659
    • Flanigan, R.C.1    Salmon, S.2    Blumenstein, B.A.3
  • 7
    • 0035934596 scopus 로고    scopus 로고
    • Radical nephrectomy plus interferon-alpha based immunotherapy compared with interferon-alpha alone in metastatic renal cell carcinoma: A randomised trial
    • Mickisch GH, Garin A, van Poppel H et al. Radical nephrectomy plus interferon-alpha based immunotherapy compared with interferon-alpha alone in metastatic renal cell carcinoma: a randomised trial. Lancet 2001; 358: 966-70
    • (2001) Lancet , vol.358 , pp. 966-970
    • Mickisch, G.H.1    Garin, A.2    Van Poppel, H.3
  • 8
    • 0036346363 scopus 로고    scopus 로고
    • Cytoreductive nephrectomy: Is it a realistic option in patients with renal carcinoma?
    • Bromwich E, Hendry D, Aitchison M. Cytoreductive nephrectomy: is it a realistic option in patients with renal carcinoma? BJU Int 2002; 89: 523-5
    • (2002) BJU Int , vol.89 , pp. 523-525
    • Bromwich, E.1    Hendry, D.2    Aitchison, M.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.